Hetero Biopharma, the biologics arm of Hetero, after successful completion of two webinars for Oncologists and with a mission of REACH-ing every partner, prescriber organized third consecutive interactive webinar session under its knowledge exchange platform KBB(Knowledge Beyond Borders) on “Kidney disease & Renal Replacement Therapy in times of Novel Corona Virus Disease 2019(COVID-19) pandemic.

Dr.Darshan Rangaswamy MD, DM ISN Fellow(Multi-organ transplant, Sydney) Associate professor from Kasturba hospital, Manipal a renowned nephrologist, has narrated the session. Also, two key nephrologists Dr.Muhammad Rafiqul Alam and Dr.Shamim Ahmed from Bangladesh has chaired as panellists for the entire session on current challenge of COVID-19 in renally compromised patients has gathered more than 105 Nephrology doctors from 15 countries of Asia and Africa.

The speaker has focussed on the multiple aspects of renally compromised patients, including dialysis management, post-dialysis management, renal transplant and the advantage of long-acting Darbepoetin(Derise) over other ESAs in anaemia management in chronic kidney disease.

The session has thrown light on the International Society of Nephrology guidelines on safety measures to be followed by patients and health care workers during dialysis. It was a mutual pass on of information on good clinical practice the doctors of following in their respective countries.

Also, the participation of our strategic business partners from Myanmar, Bangladesh and Sri Lanka has boosted the confidence among their customers It was appreciable efforts put in by our strategic business partners to bring the doctors onto a single platform in learning and sharing updated treatment protocols in nephrology.